Urgent Care for the Elderly: Impairment and Home Care Services (EPIGER)

September 8, 2016 updated by: Anne-Laure Feral-Pierssens, European Georges Pompidou Hospital

Elderly population is increasing quickly and their need for health care ressources through emergency care is also growing. While these patients are ageing physical impairment often happens along the way. Apart from senior homes, different types and levels of home care services have been developped in order to overcome or to adapt to these situations.

Our goals are:

  • to assess mortality rate depending on home care services level for the elderly population consulting in the ED or being taken in charge by the Emergency Medical System in France.
  • to describe this population in terms of autonomy, impairment and home care services

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

3200

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

80 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients aged 80 and over visiting the ED, taking in charge by SMUR (medical EMS) or calling SAMU (medical call center) during 24 hours

Description

Inclusion Criteria:

  • patients aged 80 and over

Exclusion Criteria:

  • aged<80 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality rate at hospital discharge
Time Frame: At hospital discharge or 30 days at most
Mortality rate at hospital discharge
At hospital discharge or 30 days at most

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Admission rate
Time Frame: Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
Admission in a medical, surgical or psychiatric unit are considered
Admission is decided on the first 24 hours after EMS or ED care, the day of the inclusion
Level of home care services
Time Frame: Questionnaires given the day of the inclusion
Different items in a questionnaire are asked to the patient or family concerning weekly home care services use for patient usually (which type and how often)
Questionnaires given the day of the inclusion
Level of health care ressources
Time Frame: During the ED visit (less than 24 hours), the day of the inclusion
Lab investigations, radiology, surgery, treatment administered
During the ED visit (less than 24 hours), the day of the inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

September 1, 2016

First Submitted That Met QC Criteria

September 8, 2016

First Posted (Estimate)

September 14, 2016

Study Record Updates

Last Update Posted (Estimate)

September 14, 2016

Last Update Submitted That Met QC Criteria

September 8, 2016

Last Verified

September 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • EPIGER

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Impaired

3
Subscribe